Please enable Javascript
Blood Cancer Talks
This podcast focuses exclusively on the management of blood cancers and hematology. The twice-monthly episodes are hosted by Rajshekhar Chakraborty, MD; Ashwin Kishtagari, MD; and Edward Cliff, MD.
Advertisement
How to Manage Relapsed FLT3-positive AML
Blood Cancer Talks
Blood Cancer Talks
|
November 21, 2023
Alexander Perl, MD, joins the hosts to discuss the management of newly diagnosed and relapsed FLT3-positive AML.
Listen Now
Azra Raza, MD, on Caring for Patients at the End of Life
Blood Cancer Talks
Blood Cancer Talks
|
November 8, 2023
The episode also discusses Dr. Raza's book, "The First Cell," which recounts stories of her patients with terminal cancer.
Listen Now
What Are the Best Approaches to Managing CNS Lymphoma?
Blood Cancer Talks
Blood Cancer Talks
|
October 18, 2023
Kate Cwynarski, MBBS, PhD, of the University of College London, discusses the management of CNS lymphomas.
Listen Now
What Is the Prognostic Impact of (11;14) in Myeloma?
Blood Cancer Talks
Blood Cancer Talks
|
October 18, 2023
This episode of "Blood Cancer Talks" discusses the biology and management of multiple myeloma and the role of venetoclax.
Listen Now
Dr. Kaiser Outlines the Latest Data on High-Risk Multiple Myeloma
Blood Cancer Talks
Blood Cancer Talks
|
October 2, 2023
The episode also highlights the S1211 study, which is the first randomized controlled trial with high-risk enrichment in MM.
Listen Now
Steven Horwitz, MD, Discusses Critical Trials in PTCL
Blood Cancer Talks
Blood Cancer Talks
|
August 31, 2023
Dr. Horwitz and the hosts focus on the three most common types of PTCL and the latest research.
Listen Now
Advertisement
What's the Best Way to Approach CCUS Management?
Blood Cancer Talks
Blood Cancer Talks
|
August 21, 2023
Uma Borate, MBBS, joins the hosts to discuss CCUS and the latest data.
Listen Now
What Are the Latest Strategies for Managing Paroxysmal Nocturnal Hemoglobinuria?
Cecilia Brown
Blood Cancer Talks
|
July 31, 2023
Dr. Brodsky and the hosts discuss treatment options for PNH and key recent research on the subject.
Listen Now
How Has Treatment Evolved for Newly Diagnosed Hodgkin Lymphoma?
Blood Cancer Talks
Blood Cancer Talks
|
July 19, 2023
Dr. Bartlett and the hosts explore the history of first-line treatments for patients with Hodgkin lymphoma.
Listen Now
How to Manage Acute Toxicities After CAR-T Treatment?
Blood Cancer Talks
Blood Cancer Talks
|
June 30, 2023
Dr. Jain discusses how he addresses the acute toxicities that can arise after CAR T-cell therapy.
Listen Now
Key CAR-T Developments in Multiple Myeloma Presented at ASCO, EHA
Blood Cancer Talks
Blood Cancer Talks
|
June 24, 2023
The hosts discuss the latest data on CAR-T from the summer conference season.
Listen Now
Mikkael Sekeres, MD, on MDS Classification System Updates
Blood Cancer Talks
Myeloproliferative Neoplasms
|
June 13, 2023
Dr. Sekeres also speaks about his time on the FDA ODAC and his latest book, titled "Drugs and the FDA."
Listen Now
Ajai Chari, MD, on the MonumenTAL-1, MajesTEC-1 Trials
Blood Cancer Talks
Blood Cancer Talks
|
June 13, 2023
Dr. Chari and the hosts also discuss a phase I trial of fixed-duration cevostamab, as well as a phase I trial of ABBV-383.
Listen Now
Martin Dreyling, MD, Talks TRIANGLE Trial, MCL Management
Blood Cancer Talks
Mantle Cell Lymphoma
|
May 19, 2023
Dr. Dreyling discusses the management of newly diagnosed MCL and considerations in light of the TRIANGLE trial.
Listen Now
How is MM Managed in LMICs?
Blood Cancer Talks
Blood Cancer Talks
|
May 19, 2023
The episode was inspired by an article titled “The Underrepresented Majority" by Andrés Gómez-De León, MD.
Listen Now
Ayalew Tefferi, MD, on Risk Stratification, Treatment Considerations for Myelofibrosis
Blood Cancer Talks
Blood Cancer Talks
|
May 19, 2023
Dr. Tefferi discusses risk stratification systems for primary myelofibrosis, transplant considerations, and more.
Listen Now
Morie Gertz, MD, on Clinical Trials and Controversies in Smoldering MM
Blood Cancer Talks
Blood Cancer Talks
|
May 19, 2023
Dr. Gertz and the hosts provide an overview of risk-stratification approaches and clinical trials in smoldering MM.
Listen Now
Amy DeZern, MD, MHS, on the RACE Trial, Treatment Strategies for Acquired Aplastic Anemia
Blood Cancer Talks
Blood Cancer Talks
|
May 19, 2023
Dr. DeZern discusses the latest research in the management of acquired aplastic anemia.
Listen Now
Anand Patel, MD, on the ASAP Trial, Menin Inhibitors, Key Meeting News
Blood Cancer Talks
Blood Cancer Talks
|
May 19, 2023
Dr. Patel and the hosts discuss the phase III ASAP and Dauno-Double trials, menin inhibitors, and more.
Listen Now
What Are the Latest Treatment Strategies for Newly Diagnosed DLBCL?
Blood Cancer Talks
Blood Cancer Talks
|
May 19, 2023
This episode provides listeners with DLBCL management strategies and an overview of the latest research in the field.
Listen Now
Load More
Advertisement
Advertisement
Editorial Board
Sagar Lonial, MD, FACP
Editor-in-Chief | Chief Medical Officer of Winship Cancer Institute at Emory University School of Medicine
Guillermo Garcia-Manero, MD
Associate Editor | Chief, Section of Myelodysplastic Syndromes, The University of Texas MD Anderson Cancer Center
Elias Jabbour, MD
Associate Editor | DB Lane Cancer Research Fund Distinguished Professor in Leukemia Research, MD Anderson Cancer Center
Kami Maddocks, MD
Associate Editor | Professor of Clinical Internal Medicine in the Division of Hematology at The Ohio State University
Thomas Martin, MD
Associate Editor | Clinical Research Director, UCSF Helen Diller Family Comprehensive Cancer Center
Jerald Radich, MD
Associate Editor | Professor in the Clinical Research Division and Kurt Enslein Endowed Chair at Fred Hutch
Laurie Sehn, MD, MPH
Associate Editor | Clinical Professor of Medical Oncology, British Columbia Cancer Centre for Lymphoid Cancer